A dual-targeting peptide facilitates targeting anti-inflammation to attenuate atherosclerosis in ApoE-/- mice

被引：5

作者：

Wu, Bo ^{[1
,2
]}

Zhong, Yuanzhi ^{[1
,2
]}

Chen, Jinmin ^{[3
]}

Pan, Xianmei ^{[1
,2
]}

Fan, Xianglin ^{[1
,2
]}

Chen, Peier ^{[1
,2
]}

Fu, Chenxing ^{[1
,2
]}

Ou, Caiwen ^{[4
]}

Chen, Minsheng ^{[1
,2
]}

机构：

[1] Southern Med Univ, Dept Cardiol, Zhujiang Hosp, Guangzhou 510280, Peoples R China

[2] Guangdong Prov Ctr Biomed Engn Cardiovasc Dis, Guangzhou 510280, Peoples R China

[3] Guangzhou Med Univ, Cardiovasc Dept, Affiliated Hosp 1, Guangzhou 510120, Peoples R China

[4] Southern Med Univ, Affiliated Dongguan Hosp, Dongguan Peoples Hosp, Dongguan 523059, Peoples R China

来源：

CHEMICAL COMMUNICATIONS | 2022年 / 58卷 / 62期

基金：

中国国家自然科学基金;

关键词：

NF-KAPPA-B; ENDOTHELIAL DYSFUNCTION; SHEAR-STRESS; INHIBITION; ACTIVATION; EXPRESSION; CELLS;

D O I：

10.1039/d2cc01457b

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

We report a peptidic dual-targeting drug delivery platform (integrins targeting and self-assembly instructed by matrix metalloproteinases) towards inflamed endothelial cells, which improved the anti-inflammatory ability of the loaded drug (i.e., puerarin) in vitro and thus improved the antiatherogenic effect of the loaded drug (i.e., puerarin) in vivo.

引用

页码：8690 / 8693

页数：4

共 50 条

[31] Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE-/- and APOE-/-CD40L-/- mice
Smook, M. L. F.
van Leeuwen, M.
Heeringa, P.
Damoiseaux, J. G. M. C.
Theunissen, R.
Daemen, M. J. A. P.
Lutgens, E.
Tervaert, J. W. Cohen
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2008, 154 (02): : 264 - 269
[32] Chitin oligosaccharides alleviate atherosclerosis progress in ApoE-/- mice by regulating lipid metabolism and inhibiting inflammation
Hongmin Zhen
Qiaojuan Yan
Yihao Liu
Yanxiao Li
Shaoqing Yang
Zhengqiang Jiang
FoodScienceandHumanWellness, 2022, 11 (04) : 999 - 1009
[33] Chitin oligosaccharides alleviate atherosclerosis progress in ApoE-/- mice by regulating lipid metabolism and inhibiting inflammation
Zhen, Hongmin
Yan, Qiaojuan
Liu, Yihao
Li, Yanxiao
Yang, Shaoqing
Jiang, Zhengqiang
FOOD SCIENCE AND HUMAN WELLNESS, 2022, 11 (04) : 999 - 1009
[34] Role of cell cycle control and inflammation in atherosclerosis: A study with p21-/- and ApoE-/- mice
Khanna, AK
CIRCULATION, 2002, 106 (19) : 183 - 183
[35] Vasicine attenuates atherosclerosis via lipid regulation, inflammation inhibition, and autophagy activation in ApoE-/- mice
Sun, Yun
Zhu, Defen
Kong, Lingqi
Du, Wenxia
Qu, Lu
Yang, Yingfei
Rao, Gaoxiong
Huang, Feng
Tong, Xiaoyun
INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 142
[36] Jianpi Huayu Prescription Prevents Atherosclerosis by Improving Inflammation and Reshaping the Intestinal Microbiota in ApoE-/- Mice
Zhao, Hao-Ran
Xian, Qin-Chi
Zhang, Xuan-Ming
Ma, Xiao-Yu
Wang, Fu-Qiao
Wang, Rui-Si
Liu, Zhi-Jie
Zhang, Zhi-Gang
CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (03) : 2297 - 2319
[37] A dual-targeting liposome conjugated with transferrin and arginine-glycine-aspartic acid peptide for glioma-targeting therapy
Qin, Li
Wang, Cheng-Zheng
Fan, Hui-Jie
Zhang, Chong-Jian
Zhang, Heng-Wei
Lv, Min-Hao
Cui, Shu-De
ONCOLOGY LETTERS, 2014, 8 (05) : 2000 - 2006
[38] miR-31 Overexpression Exacerbates Atherosclerosis by Targeting NOX4 in apoE-/- Mice (vol 61, pg 1617, 2015)
Liu Dejun
Sun Xuelin
Ye Ping
CLINICAL LABORATORY, 2015, 61 (12) : 1979 - 1979
[39] ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability
Huang, Rumin
Sun, Yan
Liu, Ruiyi
Zhu, Boran
Zhang, Hailou
Wu, Haoxin
JOURNAL OF ETHNOPHARMACOLOGY, 2024, 327
[40] Co-administration of Dual-Targeting Nanoparticles with Penetration Enhancement Peptide for Antiglioblastoma Therapy
Miao, Deyu
Jiang, Mengyin
Liu, Zhongyang
Gu, Guangzhi
Hu, Quanyin
Kang, Ting
Song, Qingxiang
Yao, Lei
Li, Wei
Gao, Xiaoling
Sun, Mingjiang
Chen, Jun
MOLECULAR PHARMACEUTICS, 2014, 11 (01) : 90 - 101

← 1 2 3 4 5 →